Are you using NeuroQuant® in research?

Do you need to anonymize your NeuroQuant patient information? Do you want to export NeuroQuant data in spreadsheet form? Our system tools can help researchers or clinicians using NeuroQuant® with de-identifying patient data and exporting large or small amounts of data into a spreadsheet for further analysis.

3_ctxnode.pngAnonymizing Data
The Privacy tab in CTXNode, our DICOM proxy for securely uploading data to the NeuroQuant cloud, allows MRI scan data to be automatically de-identified when required by research or facility protocols. When this feature is enabled, several DICOM fields in the input scan can be rendered blank, encrypted or populated with replacement text. The de-identified fields will remain anonymized and the original subject information will not appear in NeuroQuant output.

To use this feature, NeuroQuant users will need to install the latest CTXNode and configure the Privacy settings to suit their needs.

CSV_output.pngCSV Data Export
A convenient export of all volumetric data from a user account is possible by means of the “Export as Spreadsheet” button on the Queue Manager page.  The tabular (CSV) output facilitates further research and comparison of NeuroQuant data. To get this output simply click on the icon and a file called “resultsTable.csv” will be saved or opened depending on your computer settings.

The CSV download capability is available on both the secure, cloud-based or locally installed NeuroQuant systems. Users will need to have the CSV export license installed to enable this feature.

Questions?
If you need more information or are interested in using one or both of these features, please contact us.

More Resources

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

07/29/2026

Read Your Segmentations in the Same Space You Read the Study: Native Space Outputs in NeuroQuant v5.3.0

Review lesion segmentations directly on your original MRI images with NeuroQuant® v5.3.0.

07/23/2026

What AAIC 2026 Told Us About the Future of Dementia Imaging — And Where NeuroQuant Fits

Quantitative MRI brain volumetry with NeuroQuant.
Scroll to Top